HIV RNA (NAT)

What is HIV RNA (NAT)?

Directly detects HIV genetic material (RNA), allowing the earliest detection, often before antibodies or antigen appear.

HIV RNA nucleic acid testing (NAT) looks directly for the virus's genetic material in a blood sample, offering the shortest window period of any HIV test type. It is used less often for routine screening because of its higher cost, but it plays an important role after a very recent possible exposure, when early infection is suspected due to flu-like symptoms, or to clarify an indeterminate antibody-based result. This test relates to the immune system and viral load monitoring more broadly, since a related version of this test is also used to track how much virus is present in someone already diagnosed with HIV. Clinicians order it specifically in these more targeted, time-sensitive situations.

Tests often checked alongside this

• HIV-1/2 Antibodies — the standard screening test this NAT test often supplements
• HIV-1 Antigen (p24) — another early-detection marker, though NAT typically detects infection soonest
• HIV-1 Differentiation Ab — may be used together with NAT to clarify an indeterminate result

How this can show up in how you look and feel

• Early HIV infection can be associated with flu-like symptoms such as fever, fatigue, rash, or swollen glands, though many people have no symptoms
• This test is often ordered specifically because of a recent known or suspected exposure rather than based on symptoms alone

What can affect this marker

• Time elapsed since a potential exposure, since this affects how early the virus becomes detectable
• Whether post-exposure prophylaxis or other medications have been started, which can affect results
• Overall immune and health status at the time of testing

What to track over time

• Whether repeat testing is needed if the result is negative but the exposure was very recent
• How this result fits with any prior antibody or antigen testing already performed
• If HIV is confirmed, how a related viral load version of this test is used over time to monitor treatment

What to ask your doctor

• Given how recently my possible exposure occurred, is this the right test to use now?
• Should I also consider post-exposure prophylaxis (PEP)?
• If this result is negative, when should I retest to be sure?
• How does this test relate to any other HIV testing I've already had?

This glossary entry is for informational purposes only and is not a substitute for professional medical advice. Read our Terms of Use.